EdgarLookup

Semnur Pharmaceuticals, Inc. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
Scilex Holding Co Sale 11,945,151 $16.00 $191,122,416 181,804,849 Sep 23, 2025
Xu Jiandong Purchase 510,000 $10.00 $5,100,000 510,000 Apr 11, 2022
Denali Capital Global Investments LLC Purchase 510,000 $10.00 $5,100,000 510,000 Apr 11, 2022